Purchase Order 19GE5022P0041
- Not listed
- This is a $41,180 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the acquisition of MinION MK1C basic starter packs on behalf of the CDC's operations in Thailand. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for DNA, RNA, and protein analysis, and has secured numerous prime federal contracts from...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order to Oxford Nanopore Technologies PLC for the Acquisition of COVID-19 Detection Starter Pack on Behalf of CDC Thailand. The $167,924.00 contract has a completion date of March 31, 2022 and is not associated with a set-aside designation. The work is being performed in Great Britain, United Kingdom in support of the Coronavirus COVID-19 National Interest Action.
- This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
- This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $43,168.00, is for the delivery of a TEC-REAGENT KIT and has a completion date of September 15, 2022. Oxford Nanopore Technologies Inc. is a leading provider of nanopore-based sequencing equipment, consumables, and associated services to federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
- This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
- The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company, to provide a GridION Mk1 capex sequencing system and associated lab equipment and supplies. The $126,680 contract has a completion date of December 13, 2022 and does not utilize a set-aside designation. Based on previous federal contract awards, Oxford Nanopore Technologies Inc. provides...
- Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was awarded a $9,350 firm fixed-price purchase order (Contract ID 75D30123P15957) by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, for equipment software licenses and warranties. The contract has an ultimate completion date of April 30, 2023 and does not utilize a set-aside. This award is part of Oxford Nanopore's broader portfolio of federal contracts, which include...
- This is a $12,500.00 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the acquisition of a license and warranty for the GridION device to perform whole genome sequencing (WGS) at the CDC/DGHP laboratory on behalf of the CDC in Thailand. The contract has no set-aside designation. Oxford Nanopore...
This is a $83,962.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of a COVID-19 Detection Starter Pack on behalf of CDC Thailand. The contract has a performance period that runs through May 31, 2022 and is not associated with any set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the National Institutes of Health, CDC, U.S. Department of Agriculture, and Department of Defense for the provision of next-generation genomic sequencing equipment, consumables, and associated services in support of various research initiatives. The parent company, Oxford Nanopore Technologies PLC, has also previously been awarded a $167,924 firm-fixed-price purchase order from the CDC for COVID-19 detection products. This contract supports the Coronavirus COVID-19 National Interest Action.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $84.0k | 2/14/22 |